Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.05 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.041 | 0.7 |